Compare CMTL & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMTL | BDSX |
|---|---|---|
| Founded | 1967 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.4M | 53.0M |
| IPO Year | N/A | 2020 |
| Metric | CMTL | BDSX |
|---|---|---|
| Price | $3.21 | $7.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $6.00 | ★ $32.50 |
| AVG Volume (30 Days) | ★ 276.9K | 62.9K |
| Earning Date | 01-12-2026 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $499,528,000.00 | $80,173,000.00 |
| Revenue This Year | N/A | $20.75 |
| Revenue Next Year | $5.15 | $25.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 22.29 |
| 52 Week Low | $1.19 | $3.44 |
| 52 Week High | $4.88 | $32.20 |
| Indicator | CMTL | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 58.52 | 51.69 |
| Support Level | $3.00 | $7.68 |
| Resistance Level | $3.32 | $8.17 |
| Average True Range (ATR) | 0.20 | 0.66 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 88.33 | 55.68 |
Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.